HOME
OUR TEAM
PUBLICATIONS
DISSERTATIONS
NEWS
CONTACTO
Menu
HOME
OUR TEAM
PUBLICATIONS
DISSERTATIONS
NEWS
CONTACTO
NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn’s disease: A preliminary report.
Barreiro-de Acosta M, Ouburg S, Morre SA, Crusius JBA,Lorenzo A, Potel J, Pena AS, Enrique Dominguez-Munoz J.
2010
NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn’s disease: A preliminary report.
Rev Esp Enferm Digest 2010; 102(10):591-5.
18_2010reed2010barreiro
Descarga